Skip to content

COVID-19 infection and postoperative venous thromboembolism in patient undergoing major surgery: a prospective single center cohort study

COVID-19 infection and postoperative venous thromboembolism in patient undergoing major surgery: a prospective single center cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067733
Enrollment
Unknown
Registered
2023-01-19
Start date
2023-01-19
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism

Interventions

Case series:None

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. The patient underwent major surgery; 3. ASA classification: I-IV.

Exclusion criteria

Exclusion criteria: 1. The following surgeries: Ascitic drain (drainage of peritoneal cavity), Endoscopic ultrasound, Laparoscopic ultrasound, Breast biopsy, Insertion of cardiac pacemaker, Percutaneous coronary intervention, Transluminal balloon angioplasty of coronary artery, Colonoscopy (diagnostic or therapeutic), Flexible sigmoidoscopy (diagnostic or therapeutic, Proctoscopy (diagnostic or therapeutic), Dental procedures, Cervical biopsy, Colposcopy (diagnostic or therapeutic), Any vaginal delivery (normal delivery, breech delivery, forceps delivery, vacuum delivery), Surgical termination of pregnancy, Ophthalmic operation, Bone biopsy, Injection in to joint, Muscle biopsy, Laryngoscopy (diagnostic or therapeutic), Nasendoscopy (diagnostic), Packing of cavity of nose, Bronchoscopy (diagnostic), Insertion of chest drain, Endoscopic retrograde cholangiopancreatography (diagnostic or therapeutic), Liver biopsy, Oesophago-gastro-duodenoscopy (diagnostic or therapeutic), Bladder biopsy, ESWL, Flexible cystoscopy (diagnostic), Percutaneous nephrostomy, Endovenous laser treatment for varicose veins, Insertion or removal of dialysis catheter, injection into varicose vein of leg, Transluminal (endovascular) procedures on arteries (diagnostic or therapeutic) including with open cut down to the artery, Transluminal (endovascular) procedures on veins (diagnostic or therapeutic), Insertion or removal of Hickmann line, Insertion of central venous catheter/ line, Lumbar (spinal) puncture, Percutaneous tracheostomy, Skin biopsy (including shave biopsy of skin), Therapeutic epidural injection, Vacuum dressing; 2. Unable to complete the preoperative assessment and follow-up plan; 3. Refuse to participate; 4. There are other reasons which researcher/attending doctor think that the patient is not suitable for the trial. The reasons should be recorded in the CRF.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative venous thromboembolism within 30 days;

Secondary

MeasureTime frame
Incidence of postoperative major adverse cardiac and cerebral vascular events;Incidence of total complication during perioperative period;Incidence of reoperation after surgery;Incidence of readmission after surgery;Mortality within 30 days after surgery;

Countries

China

Contacts

Public ContactHong Zhang

Peking University First Hospital

zhanghong40@hotmail.com+86 13910104660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026